
Ixoreal Biomed highlights an exploratory placebo-controlled study of SRI-81 Shatavari, alone and combined with KSM-66 Ashwagandha, published in the International Journal of Women’s Health.
FDA has issued a “no objections” GRAS approval for SG95, a new stevia product from PureCircle (Oak Brook, IL).
FDA has issued a “no objections” GRAS approval for SG95, a new stevia product from PureCircle (Oak Brook, IL). The product’s GRAS approval not only covers seven previously GRAS-approved steviol glycosides, but also two newly approved glycosides, Rebaudioside D and F, contained in SG95.
SG95 is ideally suited for applications combining both sugar and stevia, says PureCircle-products marketed for partial caloric reduction. The company is preparing for immediate commercialization.






